Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-07-18
2006-07-18
Brumback, Brenda (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007210, C530S350000
Reexamination Certificate
active
07078177
ABSTRACT:
The present invention is directed to assays that can be used to screen for compounds that act as agonists or antagonists or inverse agonists of Dynorphin A and its analogues. The assays are based upon the binding of Dynorphin A and its analogues to the rat and human MAS receptors.
REFERENCES:
patent: 5017689 (1991-05-01), Hruby et al.
patent: WO 9932519 (1999-07-01), None
Naqvi, et al. Structure-Activity Relationship Studies of Dynorphin A and Related Peptides. Peptides, 1998. 19(7): 1277-1292.
Ambroz et al. Dec. 3, 1991. The mas oncogene enhances angiotensin-induced [Ca2+]i responses in cells with pre-existing angiotensin II receptors. Biochim Biophys Acta. 1133(1): 107-111.
Tang et al. Dynorphin A elicits an increase in intracellular calcium in cultured neurons via a non-opioid, non-NMDA mechanism. J Neurophysiol. May 2000; 83(5): 2610-5.
Young et al. Jul. 1998. Characterization of the rat mas oncogene and its high-level expression in the hippocampus and cerebral cortex of rat brain. Proc Natl Acad Sci USA 85: 5339-5342.
Selbie et al, 1998. Trends in Pharmacol Sci. 19(3):87-93.
Kawanabe et al, 2003. Biochemical Pharmacology. 65: 1435-1439.
Michael Dumont et al., “Interactions of Dynorphin A and Related Peptides with Cardiac Ouabain Binding Sites,” J Mol Cell Cardiol, vol. 28, p. 615-621, (1996).
Thomas Walther et al., “Sustained Long Term Potentiation and Anxiety in Mice Lacking the Mas Protooncogene,” The Journal of Biological Chemistry, vol. 273 (No. 19), p. 11867-73, (1998).
Oliver Von Bohlen Und Halbach et al., “Interaction Between Mas and the Angiotensin AT1 Receptor in the Amygdala,” J. Neurophysiol., vol. 83 (No. 4), p. 2012-2021, (2000).
Mitsuyuki Ichinose et al., “Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages,” Journal of Neuroimmunology, vol. 60, p. 37-43, (1995).
Ahmad Sultan
Grazzini Eric
Lembo Paola
AstraZeneca AB
Brumback Brenda
Howard Zachary C.
Quartin Robin S.
LandOfFree
Method of assaying for agonists or antagonist of Dynorphin A... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of assaying for agonists or antagonist of Dynorphin A..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of assaying for agonists or antagonist of Dynorphin A... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3599628